Tue Sep 24 04:20:57 UTC 2024: ## MDxHealth Shares Plunge 9.1% on Low Volume
**NEW YORK, NY – September 24, 2024** – Shares of MDxHealth SA (OTCMKTS: MXDHF) plummeted by 9.1% on Monday, closing at $0.25. The decline comes amid low trading volume, with only 300 shares exchanged, a stark contrast to the average daily volume of 1,000 shares.
The company, a commercial-stage precision diagnostics firm, focuses on providing urological solutions globally. Their flagship products are SelectMDx and ConfirmMDx, both genomic testing solutions designed to assist physicians in identifying prostate cancer through non-invasive methods.
Despite the decline, the stock’s 50-day moving average remained steady at $0.25. MDxHealth’s financial health indicators show a debt-to-equity ratio of 1.45, a current ratio of 1.25, and a quick ratio of 1.19.
The reasons behind Monday’s drop in MDxHealth shares remain unclear. However, the low trading volume suggests the decline may be attributed to factors unrelated to company-specific news or developments.
**[Note: The original text also mentions unrelated news about other companies, which I have omitted for brevity and focus on the MDxHealth story.]**
First Piper 